SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMPs sharp rally and elevated trading activity have sparked heavy speculation, but traders cite no confirmed new catalyst; some anticipate a breakout while others warn the move may fade as in past pump-and-dump swings. Bullish discussion also points to Flexas payment and collateral thesis and its connection to Anvil, though meaningful merchant adoption and AMP demand remain unproven.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Attention centers on Cleveland-Cliffs upcoming Q3 earnings and outlook: bullish traders point to elevated hot-rolled steel prices and contract resets as potential drivers of improving profitability and debt reduction, while skeptics question whether the company can convert those conditions into profits given its debt and execution risks. Traders are also debating the possibility of a short squeeze, but that remains speculation.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS is drawing attention over the unconfirmed 80th-death milestone in its Phase 3 REGAL trial; the last disclosed count was 78, and traders are watching for a possible update around ASH. Bulls interpret the prolonged wait as a potential sign of longer survival, while bears question the companys silence and warn that the delay may not indicate GPS is working.

X-Energy, Inc. engages in the development of advanced small modular nuclear reactors and fuel technology for clean energy generation. Its solutions include Xe-100 and TRISO-X. The company was founded by Kam Ghaffarian and Eben Mulder in 2009 and is headquartered in Rockville, MD.

X-Energy Inc. - Ordinary Shares- Class A

X-Energy Inc

XE is drawing attention amid a steep selloff, which traders attribute to a bearish Piper Sandler rating, post-IPO share-supply concerns, and weakness across nuclear and AI-related stocks. Bulls see long-term potential in its small modular reactors and Amazon backing, while skeptics point to the years-long path to commercialization and continued selling pressure.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing attention as crude rises on concerns that Middle East shipping disruptions and attacks on energy infrastructure could constrain supply, alongside strikes on Russian oil facilities. Traders are split between expecting further gains from a persistent supply-risk premium and betting that diplomacy or easing tensions could unwind the rally.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Papua New Guinea, Australia, Ghana, Suriname, Argentina, Peru, Mexico, Canada, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont is drawing attention for a technical rebound, with traders pointing to support near its 50-week moving average and watching for a break of the short-term downtrend. Many expect a gold-led recovery, while others question whether the move can hold given golds sensitivity to interest-rate expectations.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transoceans new U.S. Gulf drillship contracts are drawing attention as investors weigh the added backlog against the pending all-stock Valaris merger. Bulls see the contracts and merger as improving the outlook, while skeptics focus on dilution, debt and the stocks muted reaction to positive news.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A sharp tech- and AI-led selloff has given way to a futures rebound ahead of major technology earnings, drawing attention to QQQ. Traders are divided over whether the bounce reflects durable dip-buying or a short-covering bull trap, with the Black Monday anniversary adding to cautious market chatter.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is drawing attention as traders position ahead of its upcoming Q3 earnings, weighing hopes for a favorable truck mix and production recovery against weaker vehicle sales, steep EV declines and supplier-related disruption. Sentiment is split between dip-buyers anticipating a rebound and bears concerned that the headwinds could pressure results.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is drawing attention after a steep selloff alongside AI neocloud peers, amid concerns about financing costs, debt exposure and the durability of AI infrastructure spending. Traders are divided: some call NBIS oversold and expect a rebound, while others see further downside, with bulls arguing Nebius is better positioned financially than more leveraged rivals.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Baxter to Host Third-Quarter 2026 Financial Results Conference Call for Investors

Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2026 financial results on Thursday, October 29, 2026, at 7:30 a.m. Central Time. To participate in this conference call please follow this link...

Are Investors Undervaluing Baxter International (BAX) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is Baxter International (BAX) Stock Outpacing Its Medical Peers This Year?

Here is how Baxter International (BAX) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.

Baxter Releases Inaugural Connected Hospital Report

Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the release of its 2026 Connected Hospital Report, offering new insights into how hospitals across the United States are leveraging technology investments to drive clinical and operational outcomes. Based on a survey of...

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Here's Why You Should Retain Baxter Stock in Your Portfolio for Now

BAX's portfolio reset and growth in connected care and advanced surgery support prospects, but margins, Novum IQ and China pricing remain risks.

BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure

Baxter raises its 2026 sales and earnings outlook after strong Q2 growth, though manufacturing costs, tariffs and pricing pressure margins.

Baxter Names John Rogers CFO

(RTTNews) - Baxter International Inc. (BAX), a medtech company, on Wednesday said it has appointed John Rogers as executive vice president and chief financial officer (CFO), effective October 1, 2026...

Baxter Appoints John Rogers Chief Financial Officer

Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed John Rogers as executive vice president and chief financial officer (CFO), reporting to Baxter president and chief executive officer (CEO), Andrew Hider, effective Oct. 1, 2026. This press release...

Baxter Announces Pricing for Its Upsized Cash Tender Offers

Baxter International Inc. (NYSE:BAX) (Baxter or the Company) today announced the pricing terms for its previously announced cash tender offers (each, an Offer and collectively, the Offers) of the Company's validly tendered (and not validly withdrawn) notes set forth below (the Notes) using a...

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment sells connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment focuses on the sales of specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Baxter International Inc.

Baxter Stock Logs Worst Day In 3 Months On Margin Pain And Weak Guidance — Retail Sees Long-Term Buy Opportunity

Equity

Neutral Sentiment

Track BAX stock price, charts, news and real-time market activity on Stocktwits. Join the BAX message board to follow investor discussions, retail trader sentiment, bullish and bearish signals around Baxter International Inc stock.

BAX Stock Price Today - Baxter International Inc News, Charts, Retail Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$25.28
Prev Close	$25.76
Open	$25.95
Dividend Yield	2.72%
50-Day Moving Average	$25.01
Beta	0.85
Avg. Volume	6.76M
PE Ratio	-13.11

52-Week High	$30.00
52-Week Low	$15.73
Market Capitalization	$13.07B
EPS (Annual)	-$2.05
Price to Book	2.11
Revenue Per Employee	$299,840.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

BAX Fundamentals